Immunovia to Present at Jefferies London Healthcare Conference
LUND, SWEDEN – Immunovia AB (publ) (“Immunovia”), a diagnostic company that develops and sells highly accurate blood tests for the early detection of cancer, today announced that its CEO, Patrik Dahlen, will present and participate at the Jefferies London Healthcare Conference in London, UK, on November 16[th] 2021, and invited investors to participate by webcast. Event Details:Jefferies London Healthcare ConferenceTuesday, November 16, 2021Immunovia Presentation at6:40 pm CET A webcast of the presentation will be available via the following link: https://wsw.com/webcast/jeff201/